Point72 Asset Management »

Bridgebio Pharma shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $22M 18M 1.21
2023-09-30 $14M 15M 0.96

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Dell Technologies CL C (DELL)
Union Pacific Corporation (UNP)
Boston Scientific Corporation (BSX)
Johnson Ctls Intl SHS (JCI)
NVIDIA Corporation (NVDA)
FedEx Corporation (FDX)
Microsoft Corporation (MSFT)
CSX Corporation (CSX)
Honeywell International (HON)
Thermo Fisher Scientific (TMO)
Oracle Corporation (ORCL)
Western Digital (WDC)

View all positions for Point72 Asset Management

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Aristeia Capital
D. E. Shaw & Co
Point72 Asset Management
Wells Fargo & Company
Lazard Asset Management
683 Capital Management
MacKay Shields
Wolverine Asset Management
Lord, Abbett & Co
Calamos Advisors
Weiss Asset Management LP[1
Ubs Global Asset Management Americas
SSI Investment Management

View all funds holding Bridgebio Pharma